Tubocurarine (dTC) was administered to twenty patients by intravenous infusion at a predetermined constant rate, and the twitch responses recorded at stimulus intervals of 10 seconds (0.1 Hz). In half the group dTC plasma concentrations were measured both during and following the infusion. This provided data for derivation of the pharmacokinetic parameters, two plasma concentration-response curves and the dose-response curve. The mean effective dTC plasma concentration for 50% paralysis during the infusion (onset) was 0.93 p.g/ml, but was lower post-infusion (offset) (0.54 p.g/ml, p < 0.001). The steady state dTC plasma concentration which should produce 95% paralysis was predicted to lie between 0.95 and 1.67 p.g/ml. In the range 20 to 80% paralysis the slopes of the two (log) concentration-response lines were similar, although steeper than the associated (log) dose-response regression line, the test for parallelism showed no statistical difference. Combination of the plasma concentrationresponse curve with pharmacokinetic models was used to predict the time course of paralysis in patients with normal and impaired renal function.
INTRODUCTION
Controversy continues over whether there is a relationship between the plasma concentrations of a non-depolarizing neuromuscular blocking agent and its intensity of effect. During recovery from an intravenous (IV) injection of tubocurarine (dTC), Matteo, Spector and Horowitz (1974) reported a linear relationship between the two. Concentration in the plasma is a very poor predictor of twitch depression during the distributive phase of a twocompartment kinetic model, so Hull et al. (1978) added a receptor compartment to enable reconciliation between the concentra-tions and effects of pancuronium.
As previous studies had examined ~he relationship only following a bolus injection of relaxant, we thought to examine concentrationresponse curves both during and after administration of pancuronium by infusion (Somogyi, Shanks and Triggs 1978) . The constant-rate infusion was selected to produce the entire range of paralysis within an hour, so that the relationships obtained with onset and offset could indicate the range in which a steady state plasma concentration might be expected.
The constant-rate infusion also permits construction of a dose-response curve (Shanks, Somogyi and Triggs, in press ). The doseresponse curve for dTC is "moved to the left" not only by increasing halothane concentrations (Miller et al. 1972) , but also by more rapid rates of twitch stimulation (Savarese, Ali and Antonio 1977) . As the constant-rate infusion provides a cumulative drug dosage it is possible to construct curves in the same patient from the intensities of paralysis as observed with trains of stimuli at several frequencies.
The present studies were made during and after constant-rate IV infusion of dTC in order to (a) examine the plasma concentrations of dTC both during onset and offset of paralysis, (b) relate these to the intensities of neuromuscular blockade, and (c) derive dose-response relationships for several stimulation frequencies in the one group of patients.
METHOD
Twenty adult patients (weighing 54 to 79 kg) were studied during their elective surgery. They were premedicated with pethidine 1-1.5 mg per kg one hour before operation. Anaesthesia was induced with droperidol, 5-10 mg, phenoperidine 0.5 mg, and thiopentone 100-300 mg. During the study they were ventilated mechanically via an endotracheal tube with 70% nitrous oxide in oxygen, so as to maintain an end-expired carbon dioxide of 5.0-5.2 %. Further increments of thiopentone or phenoperidine were added as necessary for maintenance of their barbiturate-nitrous oxide-narcotic anaesthesia. Deep body and limb temperatures were maintained above 36°C and 34°C respectively.
Immediately following induction the ulnar nerve was stimulated supramaximally at the elbow. During the study an isolated nerve stimulator delivered (wi~h the cathode distal) square wave pulses of 0.15 msec duration at a nominal maximum output voltage of up to 200V. In Group 1 (n = 10) a single stimulus was delivered each 10 sec (0.1 Hz) throughout the study. In Group 2 two or three single stimuli at 20 sec and 50 sec intervals were also used, interspersed with trains of stimuli delivered at frequencies between 0.2 and 5 pulses per sec (Lee and Katz 1977) .
Neurolog equipment (Digitimer, Herts) was used for stimulation and for processing the twitch responses from the region of the thumb. The mechanical twitch response was recorded from an immobilized upper limb using a linear force transducer applied at right angles to the thumb.
Compound muscle action potentials (emg) were obtained from the small muscles of the first interspace of the same hand via surface electrodes placed dorsally. Simultaneous recording on paper of the mechanical and electric~l responses were made possible by processing the emg response through a modified Neurolog 750 signal averaging system. The intensity of neuromuscular block was assessed by comparison of depression of the twitch response with its control height.
The infusion rate was calculated from the equation (Wagner, 1974) :
In another study (Ramzan, Shanks and Triggs, in press) we found that 95% paralysis was associated with a plasma dTC concentration (Cp) of 1 pg/ml, in patients whose mean plasma clearance (Clp) was 2.7 ml/min/kg. Combined with a hybrid rate constant (13) of 0.005 and a time (T), the constant-rate infusion was calculated to be 9.3 pg/kg/min.
Following control measurements all patients received dTC at this rate, administered by a McGaw volumetric infusion pump into an established IV infusion line. Cumulative dosage was calculated directly from the time-base of the recording, ignoring latency between administration and peak effect.
In Group 1 venous blood samples were drawn from the catheter used to measure central venous pressure. These were taken at five minute intervals until 20 minutes after the cessation of the infusion, then at 30, 45, 60, 90, 120, 180 and 240 minutes post infusion. Total dTe plasma concentrations were analyzed using a spectrofluorimetric technique, a method found accurate in our laboratory to 0.1 pg/m!. The plasma concentration-time data for patients in Group 1 were fitted to a two-compartment open model.
Log dose-response and log plasma concentration-response curves were constructed for the entire range of responses using the equation (Riggs, 1963) :
where R is the response (per cent paralysis) and R max its maximum (100% ). The variable (V) was either the dose CD) or the plasma concentration (Cp). EV;',ois a constant, the mean effective value for the variable at the 50% response level, and S is a power function. The data were fitted to equation 2 by an iterative least-squares nonlinear regression programme FUNFIT (Pederson 1977), using a CDC CYBER 72 computing system, with S and EV 50 as the unknown parameters. The values for Sand EVr,o for each individual patient were then used to calculate the subjects' doses and plasma concentrations for the 5%, each decile and the 95% response level. From these were derived the mean effective doses and concentrations at each response level, producing a composite curve for 5 to 95% paralysis. The relationships between the logarithm of the dose and the (log) plasma dTC concentration versus response of the composite curves were tested in the 20 to 80% response range by linear regression, and their resultant slopes examined for parallelism (Goldstein 1967) .
During offset of paralysis from dTC, linear regression of log plasma concentration (Cp) versus response (R) has been used in the equation (Wingard and Cook 1976) :
giving the intensity of paralysis (R) at a given time (1), where the plasma concentration-time data can be described by a bi-exponential equation
Equation 3 is valid only for responses in the 20 to 80% range. This range was extended by further computation with equation 2 using 11 points to derive the values for Sand EV 50 for the whole group. The plasma concentrations, e.g. during offset of action of dTC, could then be used in a similar fashion to equation 3 to predict the intensity of 5 to 95% paralysis at time (t) using the following equation:
. Values for Sand EDi\o for the whole of Group 1, and for the whole of Group 2 at each stimulation frequency were calculated by computer.
. . : .. The scales are chosen to relate maximal results; that for dTC concentrations is logarithmic. . "
RESULTS
A plasma concentration-time plot and the associated intensities of paralysis for a typical patient in Group 1 is shown in Fig. 1 . For the 10 patients of Group 1, Table 1 shows the pharmacokinetic parameters derived by computer analysis of their plasma concentration-time data.
The plasma concentration-response curves were derived using equation 2, for both onset of blockade during dTC infusion and for offset of paralysis (post-infusion) ( Table  2) . Examination of Table 2 indicates the mean effective plasma concentration at 50% paralysis (ECp~o) was lower during offset at 0.536 ",g/ml than its value for onset of 0.928 ",g/ml (p < 0.001). Computer-derived solutions using equation 2 for the power function (S) and mean effective plasma concentrations at 50% response (ECp~,) The composite (log) plasma concentrationresponse curves were linear in their central portion (Fig. 2) and the test of the difference between the two regression slopes lacked significance (p > 0.8). The slope (and intercept) during onset of paralysis was 257 (± 58), while with offset this was 265 (± 122). The composite (log) dose-response curve for Group I in the range 20 to 80% paralysis had a slope of 171 and an intercept of 154, but again the tests for parallelism were not significant (p > 0.4).
The composite curves in Group 1 (Fig. 2) were used to derive a solution for equation 2. Table 3 gives the values for Sand Cp:;o for both the onset and offset of action of dTC. It gives also the results for a similar pancuronium study, reworked from data presented elsewhere (Shanks et al. in press) .
The best fit for the dose-response data for Group 1 to equation 2 was found to be with an ED~o of 0.247 mg/kg, where S equals 3.32.
The average dose at each selected level of response was fitted to equation 2 to obtain the dose-response curves for Group 2 at each stimulus frequency examined (Table 4) .
Pooling the data for all 20 patients gave an ED~o of 0.22 mg/kg and an ED B :; of 0.53 mg/kg. Computer-derived solutions for the power function (S) and mean effective plasma concentrations at 50% response (ECp,,,) of dTC and pancuronium, based on their composite concentration-response curves (see Fig. 2 In the range 20-80% paralysis the composite (log) dose-response curves were linear, with regression slopes in the range 150 to 180. At increasing rates of stimulation (to the maximum frequency tested, 5 Hz) the values for ED:;o (and intercept) diminished, i.e. the curve shifted to the left.
DISCUSSION
The pharmacokinetic parameters for tubocurarine (dTC) in the patients of Group 1 are in broad agreement with those reported previously (Kalow 1959 , Gibaldi et al. 1972a , Wingard and Cook 1976 , Miller et al. 1977 . The largest differences are seen in the half-lives given for the terminal phase, and most authors report values which are closer to 2 hours than to 4t hours. In characterizing the log plasma concentration versus time relationship, the pharmacokinetic models for dTC are described by either a bi-or tri-exponential equation. found that the two-compartment open model was adequate to characterize their results. Miller et al. (1977) reported that the tri-exponential model of Gibaldi et al. (1972a, b) predicted better the pharmacokinetics in their study than did the model of Wingard and Cook (1976) .
The composite plasma concentrationresponse curves were sigmoid in shape and roughly parallel to each other (Fig. 2) . Under the non-steady state conditions of this study the plasma concentrations of the curves for onset and offset of paralysis should bracket those expected to be seen in steady state. The onset curve tends to be an overestimate since plasma concentrations are measured when distribution is incomplete, while the offset curve is likely to be a closer approximation of the events occurring at steady state.
Although the ECp50 is commonly reported as an index of the therapeutic efficacy of most drugs, in the case of the muscle relaxants there is greater clinical relevance in those plasma concentrations related to 95% paralysis. From table 3 this would be predicted to lie between 0.95 and 1.67 p.g of dTe per ml of plasma. In studies attempting to aohieve steady state with a bolus and infusion administration of dTC, its mean plasma concentration at 95% paralysis was 1.09 p.g/ml (Ramzan et al., in press), which is in good agreement with the above.
During offset of paralysis, linear regression of the central part of the composite (log) plasma concentration-response curve gave a slope of 265 and an intercept of 122. Wingard and Cook (1976) from the dTC data of Matteo et al. (1974) , calculated a slope of 295 with an intercept of 66. This is in good agreement, particularly if it is assumed that the more rapid stimulus frequency in the original study (0.3 Hz) moved the plasma concentration-response curve to the left. Miller et al. (1977) not only examined the pharmacokinetics of dTC in man with and wi t>h out renal failure; they also found that although absence of renal function significantly prolonged the duration of neuromuscular blockade, it did not alter the plasma concentrations of dTC required for neuromuscular blockade. Their normal patients took 95 minutes for recovery to 80% paralysis, but in patients without renal function this took 180 minutes. The decline in plasma concentration described in their tri-exponential model is analogous to equation 4, except for the addition of a further exponential term. Using the dTC post-infusion offset curve (Table 4 ) in equation 5, the intensity of paralysis at time (t) can be predicted. The pharmacokinetic data of Miller et al. (1977) was used to calculate Cp (t) (tri-exponential form of equation 4), and 80% paralysis was predicted by equation 5 to occur at 99 minutes in normal patients and 174 minutes in patients without renal function. McLeod, Watson and Rawlins (1976) reported the pharmacokinetics of pancuronium in patients with normal and impaired renal function following a 4 mg dose. Their data in the offset curve using equation 5 (from Table  3 ) gave predictions in agreement with results reported by d'Hollander, Camu and Sanders (1978) .
Pharmacodynamic models have been constructed for pancuronium (Hull et al. 1978) and for dTC (Stanski, personal communication). Both of these utilize an additional minute compartment in order to account satisfactorily for all the observed changes in muscle twitch response, which equation 5 cannot do.
When stimulated indirectly, the curarized muscle preparation shows an "apparent inhibition" in its response to stimuli repeated rapidly (Wedensky 1885) . A series of pulses administered at 10 sec intervals produces a marked decline in its responses, quite comparable with the decline of the tetanic response when more frequent stimuli are employed (Rosenblueth and Morison, 1937) . Laboratory studies showed a shift to the left of the dose-response curves for dTC when the time interval between stimuli was decreased (Chou 1947, Preston and Van Maanen 1953) . Dose response studies in man commonly have employed a twitch stimulus interval of 3-4 sec (Miller et al. 1972 , Donlon, Ali and Savarese 1974 , Goudsouzian et al. 1975 . The results in Table 4 suggest that our patients would have provided a higher ED iio than the above studies at such stimulation frequencies. Reduction of the stimulus frequency to 0.15 Hz gave an ED50 of 0.26 mg/k~ and an EDmi of 0.51 mg/kg Antonio 1977, AIi and , results comparable with our pooled data for 0.1 Hz. While previous stimuli do not appear to affect the subsequent twitch response at rates slower than 0.15 Hz, there is a species difference. In (unpublished) dog studies involving steady state relaxation, reduction of the compound muscle action potential was observable at slower stimulation rates (Fig. 3) . 
